clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
NHS BRCA Testing for Those with Jewish Ancestry Huge Success
News & Features
Wearable Devices Can Predict Inflammatory Bowel Disease Flare-Ups
News & Features
Xenon Gas Inhalation Shows Promise for Alzheimer’s Disease
News & Features
Researchers Identify Immune Cells That Worsen Severe Asthma
News & Features
Breast Cancer Drug Shows Promise in Treating Blood Cancers
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Inside Precision Medicine
FoundationOne CDx Wins National Coverage Decision Across All Solid Tumors
Health insurance
Molecular Dx
FoundationOne CDx Wins National Coverage Decision Across All Solid Tumors
March 19, 2018
0
News & Features
FDA, CMS Pursue Concurrent Reviews for ‘Innovative’ Diagnostics
Alex Philippidis
January 22, 2018
0
Molecular Dx
Clinical Lab Group Sues HHS Over Proposed PAMA 2018 Medicare Rates
Alex Philippidis
December 14, 2017
0
Molecular Dx
CMS Proposes Coverage for Thermo Fisher Scientific NSCLC Diagnostic
Alex Philippidis
December 7, 2017
0
News & Features
Anthem, UnitedHealthcare Move toward Quicker Prior Authorizations for Some Tests
Alex Philippidis
October 2, 2017
0
Molecular Dx
Laboratories Take Aim at Proposed PAMA 2018 Medicare Rates for Tests
Alex Philippidis
September 27, 2017
0
Molecular Dx
Theranos, CMS Reach Legal Settlement
April 18, 2017
0
Molecular Dx
Human Longevity Inks Agreement to Offer Whole Genome Sequencing to MassMutual Customers
March 16, 2017
0
Molecular Dx
Study Identifies Barriers to Payer Coverage for Hereditary Cancer Panels
February 16, 2017
0
News & Features
NAS Urges “Rapid Learning System” to Accelerate Personalized Medicine
March 7, 2016
0
1
...
6
7
8
Page 7 of 8
Related Content
NHS BRCA Testing for Those with Jewish Ancestry Huge Success
Long-Read Sequencing Reveals Genetic Source of Rare Diseases
Boston-Based MedTherapy Announces New Tools for CAR-T Manufacturing
Molecular Dynamics Reveal Fast vs. Steady CAR T Cell Therapy Behavior
Inside Precision Medicine
![A final National Coverage Determination (NCD) of the Centers for Medicare & Medicaid Services allows Medicare and Medicare Advantage patients to be reimbursed for next generation sequencing (NGS) testing across all solid tumors with Foundation Medicine’s FoundationOne CDx comprehensive genomic profiling assay. [Foundation Medicine]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1541-768x576.png "FoundationOne CDx Wins National Coverage Decision Across All Solid Tumors")
![[Source: zimmytws / Adobe Stock]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1441-768x513.jpeg "FDA, CMS Pursue Concurrent Reviews for ‘Innovative’ Diagnostics")
